Smith & Nephew Announces Next Generation TRIVEX™ System For Removal Of Varicose Veins


Smith & Nephew's (NYSE:SNN; LSE: SN) Endoscopy division today announced the launch of the next generation TRIVEX™ System for the minimally invasive removal of varicose veins. The new all-in-one system now includes a precision-controlled surgical pump to provide consistent delivery of an anesthetic solution and better visualization for accurate targeting and removal of diseased veins.

The TRIVEX™ System revolutionized varicose vein removal when it was introduced in 2000. The minimally invasive TRIVEX™ procedure uses a technique called transilluminated powered phlebectomy. Transillumination is a unique feature - much like a flashlight placed under the skin - that allows a surgeon to see, accurately target and remove varicose veins, then visually confirm the extraction. Traditional varicose vein surgery is considered a "blind procedure," meaning that surgeons cannot see the vein or confirm removal.

Clinical feedback from surgeons led to an updated all-in-one modernized product design that better enables surgeons to apply standardized technique. In addition, improved and user-friendly ergonomic features such as foot switches and hand controls, together with the use of technologically advanced lightweight materials further simplifies this minimally invasive technique for removal of varicose veins.

"Traditional varicose vein removal procedures were painful for patients and arduous for surgeons. As a result patients delayed treatment and a limited number of surgeons offered the surgery,"said Gregory Spitz, M.D., F.A.C.S., Rush-Copley Medical Center, Aurora, IL and inventor of the TRIVEX™ System developed with Smith & Nephew. "he newest TRIVEX™ System and updated technique simplifies and reduces procedure time for the benefit of both surgeons and patients."

To date more than 36,000 TRIVEX™ procedures have been performed by 1,700 surgeons in over 30 countries.

"The new TRIVEX™ System further demonstrates our commitment to innovation and surgeon collaboration that results in the development of leading edge products that enable surgeons to deliver better patient care and outcomes,"said Jim Taylor, president, Smith & Nephew Endoscopy.


About Smith & Nephew

Smith & Nephew (NYSE:SNN, LSE:SN) is one of the world's leading medical devices companies, specializing in Orthopaedics, Endoscopy and Advanced Wound Management. Smith & Nephew ranks as the global leader in arthroscopy and advanced wound management and is the fastest growing full-line orthopaedics company in the world.

Smith & Nephew is dedicated to helping improve people's lives. The company prides itself in the strength of its relationships with its surgeon and healthcare professional customers, with whom its name is synonymous with the highest standards of performance, innovation and trust. The company has over 7,000 employees and operates in 32 countries around the world, generating sales of nearly $2 billion.

This press release contains forward-looking statements. The company wishes to caution the reader that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with new product development and commercialization, clinical trials, intellectual property, regulatory approvals, competitive offerings, the company's overall business strategy and other factors.


Contact

Joe Metzger
Smith & Nephew Endoscopy
(978) 749-1330